| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England Journal of Medicine 383 (6), 517-525, 2020 | 1635 | 2020 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 881* | 2021 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 678 | 2020 |
| Therapeutic anticoagulation with heparin in critically ill patients with Covid-19 EC Goligher, CA Bradbury, BJ McVerry, PR Lawler, JS Berger, MN Gong, ... New England Journal of Medicine 385 (9), 777-789, 2021 | 568 | 2021 |
| Comparison of saliva and nasopharyngeal swab nucleic acid amplification testing for detection of SARS-CoV-2: a systematic review and meta-analysis G Butler-Laporte, A Lawandi, I Schiller, M Yao, N Dendukuri, ... JAMA internal medicine 181 (3), 353-360, 2021 | 343 | 2021 |
| Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection EG McDonald, J Milligan, C Frenette, TC Lee JAMA internal medicine 175 (5), 784-791, 2015 | 294 | 2015 |
| Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open Forum Infectious Diseases 7 (4), ofaa130, 2020 | 258 | 2020 |
| Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis AD Bai, CKL Lo, AS Komorowski, M Suresh, K Guo, A Garg, P Tandon, ... Clinical Microbiology and Infection 28 (8), 1076-1084, 2022 | 179 | 2022 |
| Hydroxychloroquine as pre-exposure prophylaxis for coronavirus disease 2019 (COVID-19) in healthcare workers: a randomized trial R Rajasingham, AS Bangdiwala, MR Nicol, CP Skipper, KA Pastick, ... Clinical Infectious Diseases 72 (11), e835-e843, 2021 | 172 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 Attacc Investigators, ACTIV-4a Investigators, Remap-Cap Investigators The New England Journal of Medicine, 2021 | 149 | 2021 |
| Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis M Renaud, C Thibault, F Le Normand, EG Mcdonald, B Gallix, C Debry, ... JAMA Network Open 4 (6), e2115352-e2115352, 2021 | 118 | 2021 |
| Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis O Del Corpo, G Butler-Laporte, DC Sheppard, MP Cheng, EG McDonald, ... Clinical Microbiology and Infection 26 (9), 1137-1143, 2020 | 114 | 2020 |
| Proton pump inhibitors and risk of gastric cancer: population-based cohort study D Abrahami, EG McDonald, ME Schnitzer, AN Barkun, S Suissa, ... Gut 71 (1), 16-24, 2022 | 113 | 2022 |
| The MedSafer study—electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial EG McDonald, PE Wu, B Rashidi, MG Wilson, É Bortolussi-Courval, ... JAMA internal medicine 182 (3), 265-273, 2022 | 95 | 2022 |
| Fluvoxamine for outpatient management of COVID-19 to prevent hospitalization: a systematic review and meta-analysis TC Lee, S Vigod, É Bortolussi-Courval, R Hanula, DR Boulware, ... JAMA network open 5 (4), e226269-e226269, 2022 | 87* | 2022 |
| Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis TC Lee, S Murthy, O Del Corpo, J Senécal, G Butler-Laporte, ZN Sohani, ... Clinical Microbiology and Infection 28 (9), 1203-1210, 2022 | 86 | 2022 |
| Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial N Ezer, S Belga, N Daneman, A Chan, BM Smith, SA Daniels, K Moran, ... bmj 375, 2021 | 77 | 2021 |
| The MedSafer study: a controlled trial of an electronic decision support tool for deprescribing in acute care EG McDonald, PE Wu, B Rashidi, AJ Forster, A Huang, L Pilote, ... Journal of the American Geriatrics Society 67 (9), 1843-1850, 2019 | 72 | 2019 |
| Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... JAMA 329 (13), 1066-1077, 2023 | 71 | 2023 |
| Canadian Rheumatology Association recommendations for the assessment and monitoring of systemic lupus erythematosus SO Keeling, Z Alabdurubalnabi, A Avina-Zubieta, S Barr, L Bergeron, ... The Journal of rheumatology 45 (10), 1426-1439, 2018 | 63 | 2018 |
Todd C. Lee MD MPH FIDSAAssociate Professor, McGill University, Montreal QCE-mail megerősítve itt: mcgill.ca
